Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 36,220 | 37,305 | 33,800 | 31,204 | 16,847 |
| Cost of Goods | 24,446 | 31,140 | 24,864 | 18,554 | 7,550 |
| Gross Profit | 11,774 | 6,165 | 8,936 | 12,650 | 9,297 |
| Operating Expenses | 20,187 | 24,770 | 20,959 | 17,759 | 10,828 |
| Operating Income | -7,967 | -18,465 | -11,159 | -4,555 | -981 |
| Interest Expense | 184 | 0 | 0 | 121 | 16 |
| Other Income | 131 | 142 | 6,250 | 0 | -121 |
| Pre-tax Income | -8,020 | -18,323 | -4,909 | -4,676 | -1,118 |
| Income Tax | -599 | -2,578 | -4,988 | -12,552 | N/A |
| Net Income Continuous | -7,421 | -15,745 | 79 | 7,876 | -1,118 |
| Net Income | $-7,421 | $-15,745 | $79 | $7,876 | $-1,118 |
| EPS Basic Total Ops | -0.18 | -0.40 | 0.00 | 0.20 | -0.03 |
| EPS Basic Continuous Ops | -0.18 | -0.41 | 0.00 | 0.21 | -0.03 |
| EPS Diluted Total Ops | -0.18 | -0.39 | 0.00 | 0.19 | -0.03 |
| EPS Diluted Continuous Ops | -0.18 | -0.39 | 0.00 | 0.20 | -0.03 |
| EBITDA(a) | $-3,451 | $-13,854 | $-7,494 | $-1,555 | $729 |